200 related articles for article (PubMed ID: 7530068)
1. Hepatitis C virus RNA and anti-N14 antibody levels during interferon alpha therapy for chronic hepatitis C.
Oketani M; Tanaka K; Sho Y; Maeda E; Miyazaki H; Arima T
Intern Med; 1994 Oct; 33(10):588-92. PubMed ID: 7530068
[TBL] [Abstract][Full Text] [Related]
2. Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection.
Urushihara A; Sodeyama T; Matsumoto A; Tanaka E
J Med Virol; 1994 Apr; 42(4):348-56. PubMed ID: 7519250
[TBL] [Abstract][Full Text] [Related]
3. [Changes in C100-3, and N14 antibodies in patients with chronic hepatitis C treated with interferon].
Sakurai K; Yagi K; Hanawa Y; Shibuya A; Shibata H; Uchiyama Y; Ohtani H
Rinsho Byori; 1994 Feb; 42(2):171-5. PubMed ID: 7511184
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
[TBL] [Abstract][Full Text] [Related]
5. Short and long-term effects of interferon on serum markers of hepatitis C virus replication.
Yatsuhashi H; Inoue O; Inokuchi K; Koga M; Nagataki S; Cha TA; Irvine B; Stempien M; Kolberg J; Urdea MS
J Gastroenterol Hepatol; 1993; 8(1):1-6. PubMed ID: 8382537
[TBL] [Abstract][Full Text] [Related]
6. Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.
Aiyama T; Yoshioka K; Hirofuji H; Kusakabe A; Yamada M; Tanaka K; Kakumu S
Dig Dis Sci; 1994 Oct; 39(10):2244-9. PubMed ID: 7924750
[TBL] [Abstract][Full Text] [Related]
7. Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis.
Magrin S; Craxì A; Fabiano C; Fiorentino G; Marino L; Almasio P; Pinzello GB; Palazzo U; Vitale M; Maggio A
J Med Virol; 1992 Nov; 38(3):200-6. PubMed ID: 1283753
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa.
Tanaka E; Kiyosawa K; Matsumoto A; Kashiwakuma T; Hasegawa A; Mori H; Yanagihara O; Ohta Y
Hepatology; 1996 Jun; 23(6):1330-3. PubMed ID: 8675147
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
Saracco G; Abate ML; Baldi M; Calvo PL; Manzini P; Brunetto MR; Oliveri F; Kuo G; Chien D; Houghton M
Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
[TBL] [Abstract][Full Text] [Related]
10. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.
Hino K; Sainokami S; Shimoda K; Iino S; Wang Y; Okamoto H; Miyakawa Y; Mayumi M
J Med Virol; 1994 Mar; 42(3):299-305. PubMed ID: 7516422
[TBL] [Abstract][Full Text] [Related]
11. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.
Quiroga JA; Herrero M; Castillo I; Navas S; Pardo M; Carreño V
J Infect Dis; 1994 Sep; 170(3):669-73. PubMed ID: 7521377
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to hepatitis C virus and hepatitis C virus infection.
Yuki N; Hayashi N; Kasahara A; Hagiwara H; Fusamoto H; Kamada T
Gastroenterol Jpn; 1993 May; 28 Suppl 5():76-9. PubMed ID: 7689512
[TBL] [Abstract][Full Text] [Related]
14. Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial.
Bresters D; Cuypers HT; Reesink HW; Mauser-Bunschoten EP; van den Berg HM; Schaasberg WP; Wilber JC; Urdea MS; Neuwald P; Lelie PN
J Med Virol; 1994 Jul; 43(3):262-8. PubMed ID: 7931188
[TBL] [Abstract][Full Text] [Related]
15. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
Nagayama R; Miyake K; Tsuda F; Okamoto H
J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and antibody profiles of chronic hepatitis C patients: relation to hepatitis C virus genotypes.
Yuki N; Hayashi N; Mita E; Hagiwara H; Oshita M; Ohkawa K; Katayama K; Kasahara A; Fusamoto H; Kamada T
J Med Virol; 1995 Feb; 45(2):162-7. PubMed ID: 7539828
[TBL] [Abstract][Full Text] [Related]
17. Anti-c100 antibodies to hepatitis C virus in patients with chronic hepatitis C virus infection treated with interferon.
Nakano Y; Kiyosawa K; Sodeyama T; Tanaka E; Yoshizawa K; Furuta K; Nakatsuji Y; Urushihara A; Furuta S
Scand J Gastroenterol; 1993 Apr; 28(4):335-42. PubMed ID: 8387696
[TBL] [Abstract][Full Text] [Related]
18. Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C.
González-Peralta RP; Fang JW; Davis GL; Gish RG; Kohara M; Mondelli MU; Urdea MS; Mizokami M; Lau JY
Dig Dis Sci; 1995 Dec; 40(12):2595-601. PubMed ID: 8536518
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus RNA in plasma and blood mononuclear cells in patients with chronic hepatitis C treated with alpha-interferon.
Ounanian A; Gueddah N; Rolachon A; Thelu MA; Zarski JP; Seigneurin JM
J Med Virol; 1995 Feb; 45(2):141-5. PubMed ID: 7775931
[TBL] [Abstract][Full Text] [Related]
20. Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up.
Diodati G; Bonetti P; Tagger A; Casarin C; Noventa F; Ribero M; Fasola M; Ruol A; Realdi G
Dig Dis Sci; 1994 Nov; 39(11):2497-502. PubMed ID: 7525169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
